Variant report
Variant | esv3383110 |
---|---|
Chromosome Location | chr19:23495475-23503145 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:42)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:42 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr19:23496706-23497071 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr19:23501811-23502717 | A549 | lung: | n/a | n/a |
3 | CEBPB | chr19:23497501-23498224 | HepG2 | liver: | n/a | chr19:23497791-23497802 |
4 | CEBPB | chr19:23497450-23498187 | IMR90 | lung: | n/a | chr19:23497791-23497802 |
5 | CEBPB | chr19:23501817-23502718 | IMR90 | lung: | n/a | n/a |
6 | CEBPB | chr19:23497699-23497873 | HepG2 | liver: | n/a | chr19:23497791-23497802 |
7 | CEBPB | chr19:23500993-23501113 | HepG2 | liver: | n/a | n/a |
8 | CEBPB | chr19:23497414-23498155 | A549 | lung: | n/a | chr19:23497791-23497802 |
9 | CEBPB | chr19:23498876-23499445 | A549 | lung: | n/a | n/a |
10 | CEBPB | chr19:23497598-23497912 | HepG2 | liver: | n/a | chr19:23497791-23497802 |
11 | CEBPB | chr19:23501814-23502681 | HepG2 | liver: | n/a | n/a |
12 | CEBPB | chr19:23499135-23499414 | HepG2 | liver: | n/a | n/a |
13 | CEBPB | chr19:23496682-23497111 | HepG2 | liver: | n/a | n/a |
14 | CEBPB | chr19:23502391-23502648 | Hela-S3 | cervix: | n/a | n/a |
15 | FOS | chr19:23500959-23501325 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr19:23502442-23502654 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr19:23502468-23502721 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr19:23500995-23501321 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr19:23495291-23495598 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOS | chr19:23500981-23501266 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | FOS | chr19:23502461-23502676 | MCF10A-Er-Src | breast: | n/a | n/a |
22 | FOS | chr19:23495319-23495602 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr19:23500996-23501320 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOS | chr19:23495268-23495652 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | FOS | chr19:23495308-23495669 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | FOS | chr19:23502601-23502657 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | FOSL2 | chr19:23495284-23495590 | MCF-7 | breast: | n/a | n/a |
28 | FOSL2 | chr19:23500969-23501330 | HepG2 | liver: | n/a | n/a |
29 | JUN | chr19:23497355-23497888 | HepG2 | liver: | n/a | n/a |
30 | JUND | chr19:23495253-23495586 | HepG2 | liver: | n/a | chr19:23495429-23495440 |
31 | JUND | chr19:23501030-23501292 | HepG2 | liver: | n/a | chr19:23501131-23501142 |
32 | JUND | chr19:23497406-23497850 | HepG2 | liver: | n/a | n/a |
33 | MAFF | chr19:23501995-23502088 | HepG2 | liver: | n/a | n/a |
34 | MAFK | chr19:23497736-23497927 | HepG2 | liver: | n/a | n/a |
35 | MAFK | chr19:23499023-23499304 | HepG2 | liver: | n/a | n/a |
36 | MAFK | chr19:23499056-23499282 | HepG2 | liver: | n/a | n/a |
37 | MYC | chr19:23502441-23502641 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | POLR2A | chr19:23498166-23498300 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | RCOR1 | chr19:23497734-23497887 | HepG2 | liver: | n/a | n/a |
40 | RXRA | chr19:23497736-23497937 | HepG2 | liver: | n/a | n/a |
41 | SMC3 | chr19:23497687-23497884 | HepG2 | liver: | n/a | n/a |
42 | ZEB1 | chr19:23497675-23497972 | HepG2 | liver: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ZNF730-2 | chr19:23500840-23500868 | XLOC_013020 |
2 | lnc-AC092329.1-2 | chr19:23497078-23497228 | NONHSAT063885 |
3 | lnc-AC092329.1-2 | chr19:23500843-23500875 | NONHSAT063885 |
4 | lnc-ZNF730-3 | chr19:23502462-23502571 | XLOC_013021 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ZNF91 | TF binding region |
ENSG00000267934 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186826056 | chr19:23495507-23495508 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs2438153 | chr19:23495516-23495517 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs140768836 | chr19:23495611-23495612 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs567205107 | chr19:23495612-23495613 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs535244439 | chr19:23495628-23495629 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs553256769 | chr19:23495646-23495647 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs190920972 | chr19:23495647-23495648 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs144718127 | chr19:23495660-23495661 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs557222014 | chr19:23495663-23495664 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs575241412 | chr19:23495693-23495694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs145783086 | chr19:23495700-23495701 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543150427 | chr19:23495701-23495702 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs561453219 | chr19:23495727-23495728 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs528542022 | chr19:23495744-23495745 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183064722 | chr19:23495769-23495770 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs559310672 | chr19:23495780-23495781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs368770943 | chr19:23495840-23495841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185252866 | chr19:23495850-23495851 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs551743164 | chr19:23495963-23495964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569927431 | chr19:23495979-23495980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544490459 | chr19:23495987-23495988 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372146992 | chr19:23496039-23496040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530524939 | chr19:23496053-23496054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548674562 | chr19:23496056-23496057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs111367927 | chr19:23496094-23496095 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567372727 | chr19:23496105-23496106 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs558298592 | chr19:23496153-23496154 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148555945 | chr19:23496224-23496225 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs571547496 | chr19:23496238-23496239 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs538807921 | chr19:23496249-23496250 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557234119 | chr19:23496257-23496258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575503378 | chr19:23496269-23496270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs10427154 | chr19:23496279-23496280 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs573560143 | chr19:23496288-23496289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs295355 | chr19:23496294-23496295 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs573166641 | chr19:23496351-23496352 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs142937907 | chr19:23496379-23496380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565371502 | chr19:23496380-23496381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112155793 | chr19:23496388-23496389 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs577923133 | chr19:23496392-23496393 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545179617 | chr19:23496413-23496414 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563597711 | chr19:23496414-23496415 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370482990 | chr19:23496460-23496461 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs537548844 | chr19:23496476-23496477 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368020323 | chr19:23496477-23496478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551317181 | chr19:23496509-23496510 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs371860201 | chr19:23496523-23496524 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs528080003 | chr19:23496531-23496532 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs112766421 | chr19:23496538-23496539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs151108702 | chr19:23496576-23496577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 16783165 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chordoma | 18071362 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Cervical cancer | 21063398 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Lung cancer | 18438408 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Colorectal cancer | 20459617 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Cancer | 20164920 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:23486400-23508000 | Weak transcription | Ovary | ovary |
2 | chr19:23489800-23498200 | Weak transcription | Aorta | Aorta |
3 | chr19:23490000-23514200 | Weak transcription | Stomach Smooth Muscle | stomach |
4 | chr19:23490400-23500800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
5 | chr19:23491800-23508400 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr19:23491800-23512800 | Weak transcription | Left Ventricle | heart |
7 | chr19:23492400-23502600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr19:23493400-23499800 | Enhancers | Placenta | Placenta |
9 | chr19:23494400-23518200 | Weak transcription | Placenta Amnion | Placenta Amnion |
10 | chr19:23494800-23496600 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
11 | chr19:23496600-23512200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
12 | chr19:23496800-23498400 | ZNF genes & repeats | Fetal Brain Female | brain |
13 | chr19:23499800-23500800 | Weak transcription | Placenta | Placenta |
14 | chr19:23500400-23516600 | Weak transcription | Right Ventricle | heart |
15 | chr19:23500800-23501000 | ZNF genes & repeats | Breast Myoepithelial Primary Cells | Breast |
16 | chr19:23500800-23505800 | Enhancers | Placenta | Placenta |
17 | chr19:23501000-23501800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
18 | chr19:23501200-23512600 | Weak transcription | Brain Cingulate Gyrus | brain |
19 | chr19:23502600-23503000 | ZNF genes & repeats | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr19:23503000-23503400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |